# Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

> **NCT06365424** · PHASE2,PHASE3 · RECRUITING · sponsor: **Xijing Hospital of Digestive Diseases** · enrollment: 117 (estimated)

## Conditions studied

- Primary Biliary Cholangitis

## Interventions

- **DRUG:** Fenofibrate
- **DRUG:** UDCA

## Key facts

- **NCT ID:** NCT06365424
- **Lead sponsor:** Xijing Hospital of Digestive Diseases
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2017-04-08
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 117 (ESTIMATED)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06365424

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06365424, "Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06365424. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*